✦ LIBER ✦
PP72 Demonstration of dose-dependent target inhibition using a quantitative biomarker assay for SB939, a potent, orally active HDAC inhibitor, in a Phase I clinical study in solid tumors
✍ Scribed by V. Novotny-Diermayr; A.-L. Liang; Y.K. Loh; H. Hentze; R. Jayaraman; K. Ethirajulu; J. Zhu; J.M. Wood
- Book ID
- 119600934
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 46 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.